Ultima Genomics and collaborators enhance multiomics capabilities by integrating gene sequencing and proteomics technologies to better characterize biological systems. Partnerships with firms like Olink and SomaLogic utilize sequencing platforms for protein identification, enabling comprehensive analyses essential for understanding complex diseases and advancing drug discovery.